DF
Insider
Douglas Forsyth
DirectorDouglas Forsyth (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Inhibrx Biosciences, Inc. (INBX). The largest single filing was $287K of INBX (2,500 sh × $114.65, as filed), executed Sep 8. The median gap between execution and disclosure was 0 days.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
purchases not yet priced
Delay-adjustediThe same average, entered at disclosure dates
–
purchases not yet priced
Filings, ttm
1
1 buys · 0 sells
Median delay
0d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$287K
shares × price, as filed
Last traded
Sep 8
Filed Sep 8
Median ADV $33.6M across their filed names
100% of their measured filings could not be priced (delisted or unquoted names). The returns above cover only what still trades.
Open performance→Volume by month
Buys $287K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
INBX
Inhibrx Biosciences, Inc.
INBX · 1 buy · 0 sells
1 filing
Recent filings
INBXPURCHASE
Inhibrx Biosciences, Inc.
View filing →
$287K2,500 sh × $114.65
Exec Sep 8
Filed Sep 8 · 4:26 PM ET